We estimate that the Former President, CEO and Director of Aura Biosciences, Inc. ($AURA), Elisabet de los Pinos, Ph.D., received a compensation of $3,956,167 in 2025. This is an increase of 8.89% from an estimated $3,604,339 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on June 29, 2026. Note that parsing errors may occur.
You can track $AURA on Quiver Quantitative's $AURA stock dashboard.
$AURA Stock Insider Trading Activity
$AURA Stock insiders have traded $AURA stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $AURA stock by insiders over the last 6 months:
- LOS PINOS ELISABET DE (See Remarks) has made 0 purchases and 2 sales selling 64,576 shares for an estimated $323,368.
- CONOR KILROY (See Remarks) has made 0 purchases and 2 sales selling 23,817 shares for an estimated $143,399.
- JANET JILL HOPKINS (Chief Medical Officer) sold 20,401 shares for an estimated $103,229
- ANTHONY S GIBNEY (See Remarks) sold 12,824 shares for an estimated $82,330
- MARK PLAVSIC (Chief Technology Officer) sold 15,890 shares for an estimated $80,244
- AMY ELAZZOUZI (Senior Vice President, Finance) has made 0 purchases and 2 sales selling 10,130 shares for an estimated $50,941.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$AURA Stock Hedge Fund Activity
We have seen 58 institutional investors add shares of $AURA Stock stock to their portfolio, and 61 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SAMSARA BIOCAPITAL, LLC removed 584,849 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,187,427
- BALYASNY ASSET MANAGEMENT L.P. added 557,654 shares (+inf%) to their portfolio in Q1 2026, for an estimated $3,730,705
- MILLENNIUM MANAGEMENT LLC added 480,289 shares (+77.8%) to their portfolio in Q1 2026, for an estimated $3,213,133
- DECHENG CAPITAL LLC removed 360,483 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,411,631
- CALIGAN PARTNERS LP added 229,864 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,537,790
- FRANKLIN RESOURCES INC removed 125,697 shares (-5.7%) from their portfolio in Q1 2026, for an estimated $840,912
- LEVIN CAPITAL STRATEGIES, L.P. removed 94,186 shares (-9.1%) from their portfolio in Q1 2026, for an estimated $630,104
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$AURA Stock Price Targets
Multiple analysts have issued price targets for $AURA recently. We have seen 2 analysts offer price targets for $AURA in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Andrew S. Fein from HC Wainwright & Co. set a target price of $24.0 on 04/29/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
